West Pharmaceutical names Michel Lagarde CEO effective August 31, replacing retiring Eric Green

Filed June 1, 2026 · Period ending May 31, 2026 · ~1 min read

Key Changes

• high

  Michel Lagarde, 52, appointed President and CEO effective August 31, 2026, succeeding retiring Eric Green. Lagarde brings pharma services experience from Thermo Fisher (EVP/COO) and Patheon (President/COO).

  Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
• medium

  Lead Independent Director Robert Friel will become Board Chair on August 31, separating CEO and Chair roles—a governance structure often viewed favorably.

  Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
• medium

  Lagarde receives $1.175M base salary, 125% target bonus ($1.469M), and $8.6M in prorated 2026 long-term incentive awards (50% performance shares, 25% RSUs, 25% options).

  Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →